ARCHIVES

ODAC Supports Approval For Taxotere In Breast Cancer, Hycamtin In Lung Cancer

This article is from The Cancer Letter archive.

Vol. 24 No. 22 | June 5, 1998

Download PDF Visit The Full Archive

Related Articles

In Brief: Cancer Act Renewal Hearings Completed ; Administration Stays With Objections To More Centers, Specific Budget Figures

February 22, 1974

Maryland Contract Leafs New FY Awards

July 25, 1975

Osteoporosis Treatments Associated With Decreased Risk Of Breast Cancer

March 26, 2010

Review Group Report: NCI Role In Drug Development Seen As Information Provider

November 6, 1998

Avastin Increases Overall Survival 3.7 Months

February 22, 2013

In Brief: Ruddon To Head Eppley Institute; Shapiro elected ACR President; ACR Medalists Named

November 3, 1989